This newsletter presents you the following key sessions:
1. PODCAST with Dr. Alexander Spira about Mobocertinib in EGFR Exon 20 Insertion–Positive Metastatic
NSCLC Patients With Disease Control on Prior EGFR TKI Therapy
2. MYLUNG consortium: prospective evaluation of molecular testing practices in patients with newly
diagnosed non-small cell lung cancer in a real-world setting
3. Efficacy of Sotorasib in KRAS p.G12C-Mutated NSCLC with Stable Brain Metastases
4. IMpower010: Impact of type and extend of prior therapy on disease-free survival in atezolizumab–
treated patients
5. Telisotuzumab vedotin in patients with previously treated c-Met overexpressing advanced NSCLC
